This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: The University of British Columbia. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Innovations by Adi Steif in Genomic Analysis
Introduction
Adi Steif is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of genomic analysis, particularly in methods for assessing genomic variation within cells. With a total of 2 patents, his work is recognized for its potential impact on cancer research and preimplantation genetic diagnosis.
Latest Patents
Adi Steif's latest patents focus on innovative methods, devices, and systems for analyzing precious samples of cells, including single cells. These inventions are designed to assess genomic heterogeneity, which is a central feature of many cancers. This heterogeneity plays a critical role in disease initiation, progression, and response to treatment. Additionally, his methods are utilized to analyze embryonic biopsies for preimplantation genetic diagnosis (PGD). Notably, one embodiment of his inventions allows for the construction of genomic and RNA-seq libraries without a pre-amplification step, enhancing the efficiency of genomic analysis.
Career Highlights
Adi Steif is affiliated with the University of British Columbia, where he continues to advance research in genomic analysis. His work is pivotal in developing techniques that can lead to better understanding and treatment of various diseases, particularly cancers.
Collaborations
Adi collaborates with notable colleagues, including Anders Klaus and Jens Huft. Their combined expertise contributes to the innovative research being conducted at the University of British Columbia.
Conclusion
Adi Steif's contributions to genomic analysis through his patents and research are shaping the future of cancer treatment and genetic diagnosis. His work exemplifies the importance of innovation in the medical field.